Cargando…
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
Clopidogrel is an antiplatelet drug that displays significant interindividual variability in treatment response. Its bioavailability depends on the function of P-glycoprotein (P-gp), which is coded by a highly polymorphic ABCB1 gene. Thus, the aim of this study was to investigate the effect of ABCB1...
Autores principales: | Mugosa, Snezana, Todorovic, Zoran, Cukic, Jelena, Sahman-Zaimovic, Majda, Djordjevic, Natasa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968540/ https://www.ncbi.nlm.nih.gov/pubmed/33817306 http://dx.doi.org/10.1515/biol-2021-0017 |
Ejemplares similares
-
Risk factors for adverse drug reactions associated with clopidogrel therapy
por: Mugosa, Snezana, et al.
Publicado: (2022) -
Adverse drug reactions and polypharmacy in cardiac patients
por: Mugoša, Snežana, et al.
Publicado: (2012) -
Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021) -
Factors affecting the development of adverse drug reactions to β-blockers in hospitalized cardiac patient population
por: Mugoša, Snežana, et al.
Publicado: (2016) -
Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients
por: Zhuo, Zhong-ling, et al.
Publicado: (2018)